Company: TEM
Filing Date: 2025-08-08
Form Type: PRE 14C
Source: 0001193125-25-176981
Chunk: 6

Company: Tempus AI, Inc.
Filing Date: 2025-08-08
Form: PRE 14C
Chunk 6
---
 NRS 78.434(5).

In connection with consideration of the Amended Articles, management of the Company and the Board consulted the Company’s independent
legal advisors, including the Company’s Nevada counsel.

A copy of the full text of the Amended Articles is included as Appendix A-1 to this Information Statement. A copy of the Amended Articles showing the changes from the Current Articles, with deleted text shown in strikethrough and added text shown as double-underlined, is included as
Appendix A-2 to this Proxy Statement.

No Dissenter’s or Appraisal Rights

No dissenter’s or appraisal rights under the NRS are afforded to our stockholders as a result of the approval of the Amended Articles. The
consent we received from the Majority Holder constitutes the only stockholder approval required under the NRS, applicable Nasdaq listing rules and our Current Articles and bylaws.

Vote Required

The vote required to
approve the Amended Articles was the affirmative vote of the holders of a majority of the voting power of our outstanding shares of capital stock. Our Class A Common Stock entitles holders thereof to one vote per share and our Class B
Common Stock entitles holders thereof to 30 votes per share, voting together as a single class.

On the Record Date, there were
168,683,769 shares of Class A Common Stock outstanding and entitled to vote and 5,043,789 shares of Class B Common Stock outstanding and entitled to vote.

Vote Obtained

NRS 78.320 and our bylaws
collectively provide that any action which may be taken at any annual or special meeting of stockholders may be taken without a meeting, without notice and without a vote, via written consent of the holders of outstanding stock having not less than
the minimum number of votes that would be necessary to authorize or take such action at a meeting at which all shares entitled to vote thereon were present and voted.

As of the date of the Written Consent, the Majority Holder held approximately 59.5% of the voting power of our outstanding voting capital
stock.

No Stockholder Notice Required Under the NRS

Pursuant to NRS 78.320(3), in no instance where action is authorized by written consent need a meeting of stockholders be called or notice
given.

INTEREST OF CERTAIN PERSONS IN MATTERS TO BE ACTED UPON

No person who has been a director or officer of the Company at any time since the beginning of the last fiscal